See more : Tanami Gold NL (TAM.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Surgery Partners, Inc. (SGRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgery Partners, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Value Added Technology Co., Ltd. (043150.KQ) Income Statement Analysis – Financial Results
- Antisense Therapeutics Limited (ANP.AX) Income Statement Analysis – Financial Results
- Tohoku Electric Power Company, Incorporated (TEPCY) Income Statement Analysis – Financial Results
- Medicover AB (publ) (MCOV-B.ST) Income Statement Analysis – Financial Results
- HKBN Ltd. (HKBNF) Income Statement Analysis – Financial Results
Surgery Partners, Inc. (SGRY)
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M | 260.22M |
| Cost of Revenue | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.20M | 669.33M | 254.18M | 169.84M | 159.35M |
| Gross Profit | 647.50M | 574.90M | 491.40M | 379.80M | 423.80M | 410.03M | 327.42M | 324.24M | 290.57M | 149.11M | 114.76M | 100.87M |
| Gross Profit Ratio | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% | 28.31% | 30.27% | 36.97% | 40.32% | 38.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Other Expenses | 198.60M | 112.40M | 60.90M | 48.60M | 75.10M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.85M | 14.32M |
| Operating Expenses | 319.50M | 214.60M | 164.90M | 145.70M | 163.70M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
| Cost & Expenses | 2.42B | 2.18B | 1.90B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.16M | 306.84M | 214.03M | 198.93M |
| Interest Income | 0.00 | 227.00M | 220.90M | 201.80M | 178.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 193.00M | 234.90M | 221.00M | 201.80M | 178.90M | 147.00M | 117.67M | 100.57M | 100.98M | 62.10M | 32.93M | 28.48M |
| Depreciation & Amortization | 118.10M | 149.60M | 137.90M | 134.20M | 116.50M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |
| EBITDA | 446.10M | 460.00M | 401.00M | 277.80M | 336.60M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
| EBITDA Ratio | 16.26% | 19.86% | 20.32% | 18.35% | 18.81% | 18.58% | 19.00% | 21.05% | 10.12% | 27.96% | 28.89% | 27.86% |
| Operating Income | 328.00M | 345.20M | 302.20M | 246.60M | 235.90M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
| Operating Income Ratio | 11.96% | 13.59% | 13.58% | 13.26% | 12.88% | 4.39% | 11.80% | 17.15% | 15.08% | 12.60% | 20.46% | 23.23% |
| Total Other Income/Expenses | -193.00M | -234.90M | -221.00M | -201.80M | -181.30M | -147.00M | -75.95M | -104.30M | -220.89M | -62.10M | -32.93M | -29.31M |
| Income Before Tax | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.30M | 31.97M |
| Income Before Tax Ratio | 4.92% | 4.34% | 3.65% | -1.01% | 2.98% | -3.90% | 6.14% | 8.05% | -7.93% | -2.80% | 8.89% | 12.29% |
| Income Tax Expense | 300.00K | 23.30M | 10.50M | -20.10M | 8.50M | 26.46M | 53.55M | 7.10M | -148.98M | 15.76M | 7.57M | 6.11M |
| Net Income | -11.90M | 87.00M | 70.70M | 1.30M | 46.10M | -205.71M | -52.99M | 9.45M | 1.43M | -65.90M | -9.06M | 1.92M |
| Net Income Ratio | -0.43% | 3.43% | 3.18% | 0.07% | 2.52% | -11.61% | -3.95% | 0.83% | 0.15% | -16.34% | -3.18% | 0.74% |
| EPS | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| EPS Diluted | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| Weighted Avg Shares Out | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
| Weighted Avg Shares Out (Dil) | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49.00M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
Surgery Partners (SGRY) Surpasses Q2 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.03 per share a year ago.
Surgery Partners, Inc. Announces Second Quarter 2023 Results
BRENTWOOD, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023.
Surgery Partners, Inc. Announces Second Quarter 2023 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., July 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2023 results before the market opens on Tuesday, August...
Healthcare demand outpacing investor expectations, boosting outlook for providers, Mizuho analysts say
Recent growth in inpatient and outpatient services has been even higher than elevated investor expectations, Mizuho Securities analysts said in a research note Tuesday. Outpatient volume grew 8% in the second quarter, compared with the year-earlier period, while inpatient volume...
Surgery Partners: Exceptional Business Economics, Trading Below Fair Value
Surgery Partners comes with a set of attractive investment criteria. SGRY's economic characteristics, such as a consistent stream of 20% returns on existing capital, are standout features in the debate. A revised growth outlook and attractive valuation support a buy...
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but potentially good business for surgery centers like Surgery Partners Inc....
Strength Seen in Surgery Partners (SGRY): Can Its 5.0% Jump Turn into More Strength?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Surgery Partners, Inc. (SGRY) Q1 2023 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference...
Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.09 per share a year ago.
Surgery Partners, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., April 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2023 results after market close on Monday, May 1,...
Source: https://incomestatements.info
Category: Stock Reports